🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

INmune Bio Inc.

INMB Healthcare
$1.73 +$0.11 (6.79%)
Market Cap: $45.99 M
Gurus Holding
2
Popularity Rank
#3663
% of Shares Held
1.08%
Net Activity (Q1 2026)
+$301,481.55

Guru Ownership Trend

Guru Analysis for INmune Bio Inc. (INMB)

INmune Bio Inc. (INMB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $497,058.41.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $301,481.55 net inflow during the quarter.

Recent activity highlights Cliff Asness who dramatically increased their stake.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$301,481.55
Total Buy Value
New Buys 1
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for INmune Bio Inc. (INMB)

Major holders include Cliff Asness ($305,458), Renaissance Technologies (RenTech) ($19,210). According to the latest reported data, 2 tracked investment managers collectively hold approximately 287,317 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $301,481.55, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in INMB during the most recent reporting period.

Yes, 1 managers opened new positions in INMB, and 1 increased their existing holdings. The total reported buy value was $301,481.55.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 1217.4% 270,317 $305,458 Q1 2026
0.00% New Buy 17,000 $19,210 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form